Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
1997 2
1998 1
1999 6
2001 4
2002 11
2003 7
2004 14
2005 11
2006 18
2007 16
2008 10
2009 13
2010 14
2011 15
2012 11
2013 7
2014 13
2015 12
2016 12
2017 14
2018 23
2019 31
2020 31
2021 22
2022 14
2023 21
2024 12
2025 9
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

332 results

Results by year

Filters applied: . Clear all
Page 1
Advances in Lung Cancer Therapy.
Galetta D. Galetta D. Cancers (Basel). 2023 May 9;15(10):2671. doi: 10.3390/cancers15102671. Cancers (Basel). 2023. PMID: 37345008 Free PMC article.
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1.
Besse B, Felip E, Garcia Campelo R, Cobo M, Mascaux C, Madroszyk A, Cappuzzo F, Hilgers W, Romano G, Denis F, Viteri S, Debieuvre D, Galetta D, Baldini E, Razaq M, Robinet G, Maio M, Delmonte A, Roch B, Masson P, Schuette W, Zer A, Remon J, Costantini D, Vasseur B, Dziadziuszko R, Giaccone G; ATALANTE-1 study group. Besse B, et al. Among authors: galetta d. Ann Oncol. 2023 Oct;34(10):920-933. doi: 10.1016/j.annonc.2023.07.006. Epub 2023 Sep 11. Ann Oncol. 2023. PMID: 37704166 Free article. Clinical Trial.
BRMS1 expression in resected lung adenocarcinoma.
Galetta D, Pizzutilo P, Longo V. Galetta D, et al. Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S364-S366. doi: 10.21037/tlcr.2018.09.20. Transl Lung Cancer Res. 2018. PMID: 30705857 Free PMC article. No abstract available.
Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis.
Monaca F, Gomez-Randulfe I, Walls G, Cantale O, Parreira A, Polidori S, Di Salvatore M, Longo V, Galetta D, Vita E, Martino A, Gambacorta MA, Boldrini L, Summers Y, Tortora G, Blackhall F, Novello S, Chan C, Bria E, Faivre-Finn C, Califano R. Monaca F, et al. Among authors: galetta d. Eur J Cancer. 2025 Jul 25;225:115592. doi: 10.1016/j.ejca.2025.115592. Epub 2025 Jun 25. Eur J Cancer. 2025. PMID: 40580810
Editorial: Recent advances in surgical management of NSCLC.
Migliore M, Galetta D, Chida M. Migliore M, et al. Among authors: galetta d. Front Oncol. 2024 Aug 8;14:1454905. doi: 10.3389/fonc.2024.1454905. eCollection 2024. Front Oncol. 2024. PMID: 39175470 Free PMC article. No abstract available.
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study.
Nebhan CA, Cortellini A, Ma W, Ganta T, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Ramaiya N, Presley CJ, Owen DH, Abou Alaiwi S, Nassar A, Ricciuti B, Lamberti G, Bersanelli M, Casartelli C, Buti S, Marchetti P, Giusti R, Filetti M, Vanella V, Mallardo D, Macherla S, Sussman TA, Botticelli A, Galetta D, Catino A, Pizzutilo P, Genova C, Dal Bello MG, Kalofonou F, Daniels E, Ascierto PA, Pinato DJ, Choueiri TK, Johnson DB, Marron TU, Wang Y, Naqash AR. Nebhan CA, et al. Among authors: galetta d. JAMA Oncol. 2021 Dec 1;7(12):1856-1861. doi: 10.1001/jamaoncol.2021.4960. JAMA Oncol. 2021. PMID: 34734989 Free PMC article.
Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database.
Reale ML, Scattolin D, Vitale A, Passiglia F, Grisanti S, Macerelli M, Galetta D, Sini C, Minuti G, Citarella F, Roca E, Agustoni F, Dodi A, Cortinovis D, Belluomini L, Ricciardi S, Veccia A, Pizzutilo EG, Scotti V, Alì G, Mazzoni F, Russo A, Pignataro D, Bulotta A, Piovano P, Sergi C, Bettini A, Genova C, Pavan A, Soto Parra HJ, Ortega C, Pozzessere D, Vavalà T, Chiari R, Zannori C, D'Aveni A, Meoni G, Giannarelli D, Malapelle U, Novello S, Bria E, Pasello G. Reale ML, et al. Among authors: galetta d. Lung Cancer. 2025 Nov;209:108762. doi: 10.1016/j.lungcan.2025.108762. Epub 2025 Sep 24. Lung Cancer. 2025. PMID: 41027387 Free article.
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database.
Reale ML, Passiglia F, Cappuzzo F, Minuti G, Occhipinti M, Bulotta A, Delmonte A, Sini C, Galetta D, Roca E, Pelizzari G, Cortinovis D, Gariazzo E, Pilotto S, Citarella F, Bria E, Muscolino P, Pozzessere D, Carta A, Pignataro D, Calvetti L, Leone F, Banini M, Di Micco C, Baldini E, Favaretto A, Malapelle U, Novello S, Pasello G, Tiseo M. Reale ML, et al. Among authors: galetta d. ESMO Open. 2024 Sep;9(9):103680. doi: 10.1016/j.esmoop.2024.103680. Epub 2024 Aug 29. ESMO Open. 2024. PMID: 39214048 Free PMC article.
Diagnostic biomarkers for lung cancer prevention.
Gasparri R, Romano R, Sedda G, Borri A, Petrella F, Galetta D, Casiraghi M, Spaggiari L. Gasparri R, et al. Among authors: galetta d. J Breath Res. 2018 Feb 6;12(2):027111. doi: 10.1088/1752-7163/aa9386. J Breath Res. 2018. PMID: 29033394 Review.
332 results